Aortic Stenosis and TAVI: New Trials, Devices and Data

Published: 02 October 2023

  • Views:

    Views Icon 2215

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

In this video series, first presented at the ESC Congress 2023 held in Amsterdam, Prof Roxana Mehran, Dr Antoinette Neylon, Dr Martin Swaans, Prof Raphael Rosenhek and Prof Haim Danenberg discuss the Expand II TAVR pivotal trial design and the rational for investigating the treatment of moderate aortic stenosis patients with Evolut™ TAVI, provide practical Echo imaging recommendations to improve aortic stenosis diagnosis in challenging cases, as well as presenting the latest TAVI clinical data on durability, including an outlook of new evidence to expect next and the innovative Evolut™ FX TAVI system.

 

Click here to watch the NOTION: Nordic Aortic Valve Intervention ESC 2023 Wrap-up.

 

Download the Evolut Low Risk Trial Data Poster Here
This programme is supported by

Learning Objectives

  • Learn more about the benefits of detecting aortic stenosis earlier and discover the rationale for the Expand II TAVR pivotal trial
  • Appreciate a case-based discussion to enhance your Echo diagnosis of aortic stenosis in challenging patients and anatomies
  • Discover new TAVI trials, devices and data on durability and indications

Target Audience

  • General Cardiologists
  • Interventional Cardiologists

More from this programme

Part 1

Welcome and Introduction

Welcome and introduction of the presenters and learning objectives by Prof Mehran and Dr Neylon.
 

1 session
Welcome and Introduction Watch now

Part 2

Treating Aortic Stenosis Earlier – What You Need to Know

Dr Swaans presents the rational for considering the treatment of moderate aortic stenosis patients and the Expand II TAVR pivotal trial design.

1 session
Treating Aortic Stenosis Earlier – What You Need to Know Watch now

Part 3

Panel Discussion – Treating Aortic Stenosis Earlier – What You Need to Know

Panel discussion about moderate aortic stenosis and the challenges to identify the symptomatic patients, as well as questions about the Expand II TAVR pivotal trial design.

1 session
Panel Discussion – Treating Aortic Stenosis Earlier – What You Need to Know Watch now

Part 4

Overcoming Echo Acquisition Challenges in Aortic Stenosis

Prof Rosenhek presents practical echo imaging tips on how to enhance the echo diagnosis of aortic stenosis in challenging patients.

1 session
Overcoming Echo Acquisition Challenges in Aortic Stenosis Watch now

Part 5

Panel Discussion – Overcoming Echo Acquisition Challenges in Aortic Stenosis

Panel discussion addressing questions on how to avoid the underdiagnosis of patients, especially in women and the importance of calcium scoring as well as the pencil probe to see the jet easier. Furthermore the panel discuss which patients we expect to be seeing in the Expand II TAVR pivotal trial for moderate aortic stenosis patients.

1 session
Panel Discussion – Overcoming Echo Acquisition Challenges in Aortic Stenosis Watch now

Part 6

TAVI Evolut-ion – Data and New Devices

Prof Danenberg presents hot off the press, new TAVI data including the sub analysis of the 3 year results of the Evolut Low Risk trial of patients below 75 years of age. He explains the differences of existing TAVI valve devices and how their design variances lead to equally different durability outcomes known so far. Furthermore he presents the new Evolut™ FX TAVI system and prospective TAVI data coming up.

1 session
TAVI Evolut-ion – Data and New Devices Watch now

Part 7

Panel Discussion – TAVI Evolut-ion – Data and New Devices

Panel discussion about the treatment of younger patients and which valve to consider, Prof Danenbergs’ experience with the new Evolut™ FX TAVI system and the importance of the commissural alignment and other innovations to help improve TAVI patient treatment outcomes.

1 session
Panel Discussion – TAVI Evolut-ion – Data and New Devices Watch now

Part 8

Take Home Message

Dr Neylon summarises the scientific session and shares the take home messages.
 

1 session
Take Home Message Watch now

Faculty Biographies

Raphael Rosenhek

Raphael Rosenhek

Director Clinic for Valvular Heart Disease

Prof Raphael Rosenhek is the Director Clinic for Valvular Heart Disease at Medical University of Vienna, Vienna, AT.

Prof Rosenhek's research interests include structural heart disease, valvular heart disease and echocardiography with a particular focus on defining the optimal timing and choice of intervention for these conditions.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.